Mechanistic studies have uncovered that in obesity, hypertrophic adipocytes exhibit upregulated aromatase expression, leading to 2–3-fold higher intratumoral estrogen levels compared to lean individuals. This evidence concerns the gene CYP19A1 and obesity due to melanocortin 4 receptor deficiency.